trial

Aerobic Exercise for Cognition in Schizophrenia

NCTId NCT02621983
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 50 (actual)
Sponsored by VA Office of Research and Development
Primary completion 2018-07-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
50 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2016-01-01
Primary completion
2018-07-01
Eligibility
ALL · 18 Years · 70 Years

Interventions & indications

Drugs
Aerobic exerciseBalance and Stretching

Sponsors

VA Office of Research and DevelopmentLead Sponsor
Emory UniversityCollaborator

Investigators

1
Erica J. Duncan, MDPrincipal Investigator

Sites

1 total
Decatur, United States

Facts & assertions

4 sourced
Enrollment
50
Phase
NA
Primary Completion Date
2018-07-01
Status
COMPLETED
relationships
The graph out of here
drug
Aerobic exercise
drug
Balance and Stretching
drug
lead_sponsor
VA Office of Research and Development
company
collaborator
Emory University
company
indication
Schizophrenia
indication
Motor Activity
indication
Schizophrenia
indication
investigator
Erica J. Duncan, MD
person